跳至主導覽 跳至搜尋 跳過主要內容

Discovery of novel EGFR and BRAF inhibitors by machine learning approach

  • Macao Polytechnic University

研究成果: Article › 同儕審查

3 引文 斯高帕斯(Scopus)

摘要

Background In the pharmaceutical industry, epidermal growth factor receptor (EGFR) and B-Raf proto-oncogene, serine/threonine kinase (BRAF) are the primary targets for targeted cancer therapy. Objective This study aimed to develop novel models for predicting the bioactivity of EGFR and BRAF inhibitors and to uncover critical substructural groups for EGFR and BRAF targets. Method K-nearest neighbor, Gaussian naive Bayes, random forest (RF), decision tree, and support vector machine models were utilized to develop classifiers for EGFR and BRAF inhibitors. In addition, the critical functional groups of these inhibitors were analyzed, and molecular docking was performed. Results The RF model was found to be the preferred choice for predicting the bioactivity of EGFR and BRAF inhibitors. The RF model for BRAF had an accuracy and area under the curve (AUC) of 93% and 0.96, respectively, and the RF model for EGFR had an accuracy and AUC of 90% and 0.96, respectively. The results of this study show the importance of properly increasing chlorine or fluorine in inhibitors of BRAF or EGFR. Moreover, the EGFR and BRAF inhibitors exhibited the same halogen selection priority of fluorine > chlorine > bromine. Conclusion The present study develops novel models for predicting the bioactivity of EGFR and BRAF inhibitors. The hydrogen bond formation is a key factor for influencing the selection priority of fluorine > chlorine > bromine.

原文English
頁(從 - 到)7-16
頁數10
期刊Intelligent Oncology
卷1
發行號1
DOIs
出版品狀態Published - 1月 2025

UN SDG

此研究成果有助於以下永續發展目標

  1. Good health and well being
    Good health and well being

指紋

深入研究「Discovery of novel EGFR and BRAF inhibitors by machine learning approach」主題。共同形成了獨特的指紋。

引用此